Form: 6-K

Report of foreign issuer [Rules 13a-16 and 15d-16]

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington. D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2004

Novogen Limited

(Translation of registrant’s name into English)

140 Wicks Road, North Ryde, NSW, 2113, Australia
(Address of principal executive office)

[Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F o

[Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes o No o

[If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2 (b): 82-           .1

 

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
        Novogen Limited
          (Registrant)
 
September 24, 2004   By   -s- RONALD LEA ERRATT
 
        Ronald Lea Erratt
Company Secretary

 

 

Appendix 3Y
Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

           
 
Name of entity
 
    NOVOGEN LIMITED  
 
ABN
 
    063 259 754  
 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

           
 
Name of Director
 
    GRAHAM EDMUND KELLY  
 
Date of last notice
 
    4 June 2004  
 

Part 1 – Change of director’s relevant interests in securities
 In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

           
 
Direct or indirect interest
 
    DIRECT AND INDIRECT  
 
Nature of indirect interest
(including registered holder)
 Note: Provide details of the circumstances giving rise to the relevant interest.
 
    PERSONALLY AND AS A DIRECTOR OF BENDE HOLDINGS PTY LTD FOR THE SALE  
 
Date of change
 
    COMPLETED 24 June, 2004  
 
No. of securities held prior to change
    6,485,538 IN BENDE HOLDINGS PTY LTD, 1,104,500 PERSONALLY, 513,654 IN COOLAWIN ROAD PTY LTD AND 7,000 in PHYTOSE CORPORATION PTY LTD
 		  
 
Class
 
    ORDINARY  
 
Number acquired
 
        
 
Number disposed
 
    140,900 AS A DIRECTOR OF BENDE HOLDINGS  
 
Value/Consideration
 Note: If consideration is non-cash, provide details and estimated valuation
 
    BENDE HOLDINGS SOLD AT AN AVERAGE OF $5.0243 PER SHARE  
 

 

Appendix 3Y
Change of Director’s Interest Notice

           
 
No. of securities held after change
    1,104,500 PERSONALLY, 6,344,638 IN BENDE HOLDINGS PTY LTD, 513,654 IN COOLAWIN ROAD PTY LTD AND 7,000 IN PHYTOSE CORPORATION PTY LTD
 		  
 
Nature of change
 Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
 
    ON MARKET TRADE  
 

Part 2 – Change of director’s interests in contracts

           
 
Detail of contract
 
       
 
Nature of interest
 
        
 
Name of registered holder
(if issued securities)
 
        
 
Date of change
 
        
 
No. and class of securities to which interest related prior to change
 Note: Details are only required for a contract in relation to which the interest has changed
 
        
 
Interest acquired
 
        
 
Interest disposed
 
        
 
Value/Consideration
 Note: If consideration is non-cash, provide details and an estimated valuation
 
        
 
Interest after change
 
        
 

24 September, 2004